[1]Wedekind M F, Widemann B C, Cote G. Chordoma: current status, problems, and future directions[J]. Curr Probl Cancer, 2021, 45(4):100771.
[2]Noor A, Bindal P, Ramirez M, et al. Chordoma: a case report and review of literature[J]. Am J Case Rep, 2020, 21: e918927.
[3]Gulluoglu S, Turksoy O, Kuskucu A, et al. The molecular aspects of chordoma[J]. Neurosurg Rev, 2016, 39(2):185-196.
[4]Simal-Julián J A, Miranda-Lloret P, Pancucci G, et al. Endonasal skull base endoscopy[J]. Neurocirugia (Astur), 2013, 24(5):210-215.
[5]Stokken J K, Halderman A, Recinos P F, et al. Strategies for improving visualization during endoscopic skull base surgery[J]. Otolaryngol Clin North Am, 2016, 49(1):131-140.
[6]McCormack P L. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis[J]. Drugs, 2012, 72(5):585-617.
[7]De Faria J L, Da Silva Brito J, Costa E Silva L T, et al. Tranexamic acid in neurosurgery: a controversy indication-review[J]. Neurosurg Rev, 2021, 44(3):1287-1298.
[8]Brown N J, Wilson B, Ong V, et al. Use of tranexamic acid for elective resection of intracranial neoplasms: a systematic review[J]. World Neurosurg, 2022, 160: e209-e219.
[9]Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss[J]. Br J Surg, 2013, 100(10):1271-1279.
[10]CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3):a randomised, placebo-controlled trial[J]. Lancet, 2019, 394(10210):1713-1723.
[11]张雪, 黄宇光. 围术期纤维蛋白原输注的临床应用进展[J]. 临床麻醉学杂志, 2020, 36(5):507-509.
[12]Mesar T, Larentzakis A, Dzik W, et al. Association between ratio of fresh frozen plasma to red blood cells during massive transfusion and survival among patients without traumatic injury[J]. JAMA Surg, 2017, 152(6):574-580.
[13]Turan A, Yang D S, Bonilla A, et al. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery[J]. Can J Anaesth, 2013, 60(8):761-770.
[14]Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis[J]. BMJ, 2012, 344: e3054.
[15]李仁华, 陈娜, 叶春艳, 等. 开颅手术后深静脉血栓形成的危险因素[J]. 中南大学学报: 医学版, 2020, 45(4):395-399.
[16]龚恒, 黄斌, 付立功, 等. 全膝关节置换术后小腿肌间静脉血栓临床研究[J]. 中国运动医学杂志, 2020, 39(11):863-869.
[17]Meretoja A, Yassi N, Wu T Y, et al. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST):a multicentre, randomised, placebo-controlled, phase 2 trial[J]. Lancet Neurol, 2020, 19(12):980-987.
[18]Murao S, Nakata H, Roberts I, et al. Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis[J]. Crit Care, 2021, 25(1):380.
[19]Lecker I, Wang D S, Whissell P D, et al. Tranexamic acid-associated seizures: causes and treatment[J]. Ann Neurol, 2016, 79(1):18-26.
[20]Guo J F, Gao X R, Ma Y, et al. Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials[J]. BMC Anesthesiol, 2019, 19(1):129.
[21]Alsubaie H M, Abu-Zaid A, Sayed S I, et al. Tranexamic acid in head and neck procedures: a systematic review and meta-analysis of randomized controlled trials[J]. Eur Arch Otorhinolaryngol, 2022, 279(5):2231-2238.
[22]De Brito R M, De Oliveira C M B, Moura E C R, et al. Tranexamic acid effects in postoperative bleeding outcomes in laparoscopic sleeve gastrectomy: a controlled study[J]. Acta Cir Bras, 2022, 37(7):e370702.
[23]Hui S Y, Peng Y, Tao L Y, et al. Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis[J]. J Orthop Surg Res, 2021, 16(1):401.
[24]Boyle J A, Soric M M. Impact of tranexamic acid in total knee and total hip replacement[J]. J Pharm Pract, 2017, 30(1):89-93.
|